Transseptal technique of percutaneous PFO closure results in persistent interatrial shunting

Catheterization and Cardiovascular Interventions

Volumn 65, Issue 2, 2005, Pages 295-300

  Tande, Aaron J ^a   Knickelbine, Thomas ^a   Chavez, Ivan ^a   Mooney, Michael R ^a   Poulose, Anil ^a   Harris, Kevin M ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

Heart septal defects; Paradoxical embolism; Patent foramen ovale closure; Transesophageal echocardiography; Transseptal puncture

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; DEVICE; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS LOOSENING; RETROPERITONEAL HEMATOMA; REVIEW; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BALLOON OCCLUSION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; PUNCTURES; RETROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED; TREATMENT FAILURE;

EID: 20344407826     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20377     Document Type: Review

References (18)

1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
2. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:1148-1152.
3. Caes FL, Van Belleghem YV, Missault LH, Coenye KE, Van Nooten GJ. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995; 59:1559-1561.
4. Meier-Ewert HK, Labib SB, Schick EC, Gossman DE, Stix MS, Williamson CA. Paradoxical embolism in the left main coronary artery: diagnosis by transesophageal echocardiography. Mayo Clin Proc 2003;78:103-106.
5. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631.
6. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
7. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol 2001;14:261-266.
8. Harris KM, Haney MF, Gerling B, Plehn JF. Systemic embolization complicating right ventricular myocardial infarction. Arch Intern Med 1995;155:111-113.
9. Tande AJ, Knickelbine T, Harris KM. Successful percutaneous closure of patent foramen ovale seven years after surgical closure. J Invas Cardiol 2003;15:410-412.
10. Ruiz CE, Alboliras ET, Pophal SG. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Catheter Cardiovasc Interv 2001;53:369-372.
11. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke 2002;33:706-711.
12. Waight DJ, Cao QL, Hijazi ZM. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices. Catheter Cardiovasc Interv 2000;50:195-198.
13. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
14. Khositseth A, Cabalka AK, Sweeney JP, Fortuin FD, Reeder GS, Connolly HM, Hagler DJ. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004;79:35-41.
15. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
16. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, Patent Foramen Ovale and Atrial Septal Aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345:1740-1746.
17. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
18. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.